The National Psoriasis Foundation has issued a statement that endorses consideration of adjunctive GLP-1 receptor agonists in ...
Hosted on MSN
GLP-1 boom drives new wave in aesthetic treatments
Aesthetic companies are capitalizing on rising demand from patients experiencing loose skin and facial changes after rapid weight loss from GLP-1 obesity drugs. Firms like Apyx Medical, InMode, ...
Friendly derma skincare brand COSRX announces its latest innovation, The Blue Peptide Bakuchiol Plump Glow Serum, powered by ...
For many patients without a primary care provider, a dermatologist may be the only healthcare professional who can counsel ...
While most people are now familiar with GLP-1 agonists they represent just one category of peptide-based therapies.
Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity ...
With the GLP-1 drug market expanding after the patent expiry of semaglutide in India, doctors expect demand to grow ...
Aesthetic companies are increasingly targeting patients using GLP-1 weight-loss drugs, anticipating demand for treatments addressing loose skin and facial volume loss. Firms such as Allergan ...
Add Yahoo as a preferred source to see more of our stories on Google. “The battery must be dead.” That’s what I thought the first time my Amazon scale couldn’t register my weight. At five feet three ...
ALEXANDRIA, VA, UNITED STATES, April 29, 2026 /EINPresswire.com/ -- Today, the National Psoriasis Foundation (NPF) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results